Jodi Fenlon Rebuffoni's 3-year-old son, Maceo, couldn't sleep.
He was supposed to be taking part in a medical study of his sleeping problems, but all the wires and electronic gizmos glued to his body kept the Minneapolis boy awake. Rebuffoni's frustration reached the breaking point when she realized the tech industry had made sure she could use her phone to turn up her stereo speakers, yet no one had invented truly wireless monitors so kids like Maceo could sleep during sleep studies.
Over at the University of Minnesota, pediatric critical care physician Dr. Gwenyth Fischer experienced a different aspect of the same problem. She invented a device to prevent adrenaline overdoses in children having heart attacks, but commercial interest in testing and selling it was nil.
The problem in both cases is the "home run" model of medical device innovation. The venture investors that pay for much of the early-stage medical device innovation in the U.S. typically insist on strong financial projections before backing a device because the risk of failure is high. Profit targets of $500 million or more for a new medical device are often mentioned.
Kids' wireless sleep-study monitors and preloaded adrenaline syringes are unlikely to ever produce the kind of profits that someone could retire on. But rather than just vent about the well-documented challenges facing pediatric medical devices, Fischer in 2011 founded a volunteer group that uses the resources of the University of Minnesota and the local medical-device industry to get such devices on the market.
Incubating ideas
The group, called the Pediatric Device Innovation Consortium (PDIC), is using traditional methods like grants and close collaboration with inventors to kick-start new devices. For 2016, the group is planning to offer access to a pediatric device incubator plus a public outreach program to solicit ideas from not just engineers and doctors, but concerned parents.
The university's Office of Discovery and Translation, where Rebuffoni is project manager, will provide about $250,000 in 2016 to fund PDIC programs with the goal of overcoming regulatory, scientific and financial barriers that keep lifesaving devices for children off the market.
"What we'd like to do is take products as far as possible with university help, so that when they exit the university system into industry, they are much more likely to succeed," Fischer said. "Essentially, the more hurdles we can take on for industry, the more likely they are to take that product and run with it."